CliffBio
small molecule

CIMETIDINE HYDROCHLORIDE

CIMETIDINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyCycle Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameCIMETIDINE HYDROCHLORIDE
Active ingredientCIMETIDINE HYDROCHLORIDE
StrengthEQ 300MG BASE/5ML
Dosage formSOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalAugust 1997
Marketing statusDISCN

More from Cycle Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

CIMETIDINE HYDROCHLORIDE patent cliff — loss of exclusivity — | CliffBio